Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Jeffrey John Hagen, Plymouth US

Jeffrey John Hagen, Plymouth, MN US

Patent application numberDescriptionPublished
20090156988Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. Some involve implementing or deploying therapeutic administration systems, for example, for obtaining a priori implant information and signaling a decision whether to initiate implant-site-targeting treatment partly based on the a priori implant information and partly based on one or more other clot-indicative determinants; or obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement; or obtaining one or more indications of a lytic material in a vicinity of one or more body lumens and accelerating a decrease in a local concentration of the lytic material in the vicinity of the one or more body lumens by causing one or more elements to extract at least a portion of the lytic material in the vicinity of the one or more body lumens in response to the one or more indications of the lytic material in the vicinity of the one or more body lumens; or one or more capture components configured to accelerate a decrease in a local concentration of one or more therapeutic structures along a downstream portion of a vasculature and one or more dispensation components configured to release the one or more therapeutic structures into an upstream portion of the vasculature.06-18-2009
20090157056Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. Some involve implementing or deploying therapeutic administration systems, for example, for obtaining a priori implant information and signaling a decision whether to initiate implant-site-targeting treatment partly based on the a priori implant information and partly based on one or more other clot-indicative determinants; or obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement; or obtaining one or more indications of a lytic material in a vicinity of one or more body lumens and accelerating a decrease in a local concentration of the lytic material in the vicinity of the one or more body lumens by causing one or more elements to extract at least a portion of the lytic material in the vicinity of the one or more body lumens in response to the one or more indications of the lytic material in the vicinity of the one or more body lumens; or one or more capture components configured to accelerate a decrease in a local concentration of one or more therapeutic structures along a downstream portion of a vasculature and one or more dispensation components configured to release the one or more therapeutic structures into an upstream portion of the vasculature.06-18-2009
20090157057Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. Some involve implementing or deploying therapeutic administration systems, for example, for obtaining a priori implant information and signaling a decision whether to initiate implant-site-targeting treatment partly based on the a priori implant information and partly based on one or more other clot-indicative determinants; or obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement; or obtaining one or more indications of a lytic material in a vicinity of one or more body lumens and accelerating a decrease in a local concentration of the lytic material in the vicinity of the one or more body lumens by causing one or more elements to extract at least a portion of the lytic material in the vicinity of the one or more body lumens in response to the one or more indications of the lytic material in the vicinity of the one or more body lumens; or one or more capture components configured to accelerate a decrease in a local concentration of one or more therapeutic structures along a downstream portion of a vasculature and one or more dispensation components configured to release the one or more therapeutic structures into an upstream portion of the vasculature.06-18-2009
20090157058Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. Some involve implementing or deploying therapeutic administration systems, for example, for obtaining a priori implant information and signaling a decision whether to initiate implant-site-targeting treatment partly based on the a priori implant information and partly based on one or more other clot-indicative determinants; or obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement; or obtaining one or more indications of a lytic material in a vicinity of one or more body lumens and accelerating a decrease in a local concentration of the lytic material in the vicinity of the one or more body lumens by causing one or more elements to extract at least a portion of the lytic material in the vicinity of the one or more body lumens in response to the one or more indications of the lytic material in the vicinity of the one or more body lumens; or one or more capture components configured to accelerate a decrease in a local concentration of one or more therapeutic structures along a downstream portion of a vasculature and one or more dispensation components configured to release the one or more therapeutic structures into an upstream portion of the vasculature.06-18-2009
20090284378Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects.11-19-2009
20090287093Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects.11-19-2009
20090287094Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects.11-19-2009
20090287101Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects.11-19-2009
20090287109Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects.11-19-2009
20090287110Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects.11-19-2009
20090287120Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects.11-19-2009
20090287191Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects.11-19-2009
20090292212Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects.11-26-2009
20090292213Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects.11-26-2009
20090292214Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects.11-26-2009
20090292222Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects.11-26-2009
20100036209Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects.02-11-2010
20100036263Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects.02-11-2010
20100036268Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects.02-11-2010
20100036269Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects.02-11-2010